Discover 1,825 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,825
Health Effects of Repeated Exposure to Low Levels of Concentrated Ambient Particles in Healthy Young Volunteers
for
Air Pollution
Location: Chapel Hill NC
Sponsor: U.S. EPA Human Studies Facility
Sex: All
Age: 18 - 35
Code: NCT05323240
Recruiting
The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
for
Toxicity, Radiation Toxicity
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT04700527
Phase 1, Phase 2, Recruiting
Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment
for
Cervical Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: Female
Age: 18+
Code: NCT04743674
Recruiting
A Prospective Trial to Identify Biomarkers Involved in the Transition From Acute to Persistent Chronic Low Back Pain
for
Acute Low Back Pain, Chronic Low Back Pain
Location: Winston-Salem NC
Sponsor: University of Parma
Sex: All
Age: 18 - 70+
Code: NCT02037763
Recruiting
Management of Chronic Pain in Military Patients With Injuries Sustained During Active Duty
for
Extremity Injury
Location: Winston Salem NC
Sponsor: Sceptor Pain Foundation
Sex: All
Age: 18+
Code: NCT01616342
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of MF101 in Postmenopausal Women
for
Hot Flushes, Vasomotor Symptoms
Location: Winston-Salem NC, Raleigh NC, Charlottesville VA,
Sponsor: Bionovo
Sex: Female
Age: 40 - 65
Code: NCT00906308
Phase 3, Recruiting
Evaluating a New Program for Successfully Coping With Adversity
Location: Greensboro NC, Cary NC, Wake Forest NC, Hickory NC,
Sponsor: Adverum Biotechnologies, Inc.
Sex: All
Age: 50+
Code: NCT07482176
Phase 3, Recruiting
Active & Responsive
A Study of YL201 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Chapel Hill NC, Fairfax VA, Washington D.C. DC,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT05434234
Phase 1, Phase 2, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
for
Solid Tumors Harboring MET Amplification
Location: Durham NC, Fairfax VA, Nashville TN, New York NY,
Sponsor: AbbVie
Sex: All
Age: 12+
Code: NCT07196644
Phase 2, Recruiting
Featured
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
for
Non-Small Cell Lung Cancer,
Location: Durham NC, Huntersville NC, Fairfax VA, Louisville KY,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT05005403
Phase 1, Recruiting
Featured
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia (CLL)
Location: Winston-Salem NC, Chapel Hill NC, Charlotte NC,